VACCHERI, ALBERTO
VACCHERI, ALBERTO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
A 3 year survey on the use of antibacterial agents in five Italian hospitals.
2008 Vaccheri A; Silvani MC; Bersaglia L; Motola D; Strahinja P; Vargiu A; Poluzzi E; Montanaro N.
A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital.
2009 Silvani M.C.; Poluzzi E.; Motola D.; Quaranta P.; Nanetti A.; Ambretti S.; Fiacchi P.; Puggioli C.; Vaccheri A.; Montanaro N.
Acute renal failure in patients treated with dronedarone or amiodarone: A large population-based cohort study in Italy
2015 Conti, Valentino; Biagi, Chiara; Melis, Mauro; Fortino, Ida; Donati, Monia; Vaccheri, Alberto; Venegoni, Mauro; Motola, Domenico
Aderenza al trattamento con Bifosfonati: studio di coorte retrospettivo su database amministrativi dell’Emilia Romagna
2010 Puccini A; Piccinni C; Sacripanti C; Gadaleta A; Vaccheri A;
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage
2007 Poluzzi E.; Strahinja P.; Vaccheri A.; Vargiu A.; Silvani M.C.; Motola D.; Marchesini G.; De Ponti F.; Montanaro N.
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage.
2006 Poluzzi E; Strahinja P; Vargiu A; Silvani MC; Motola D; Vaccheri A; De Ponti F; Marchesini Reggiani G; Montanaro N.
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy
2008 Poluzzi E; Strahinja P; Lanzoni M; Vargiu A; Silvani MC; Motola D; Gaddi A; Vaccheri A; Montanaro N.
An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals.
2007 Silvani MC; Bersaglia L; Poluzzi E; Motola D; Bottoni A; Strahinja P; Vargiu A; Vaccheri A; Montanaro N.
An update on the first decade of the European centralized procedure: how many innovative drugs?
2006 Motola D.; De Ponti F.; Poluzzi E.; Martini N.; Rossi P.; Silvani M.C.; Vaccheri A.; Montanaro N.
Antibacterial prescription in Italian preschool children: analysis of 7 years of data from the Emilia-Romagna region reimbursement database
2019 D'Annibali O.; Bonaldo G.; Donati M.; Smabrekke L.; Motola D.; Vaccheri A.
Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital.
2008 M. C. Silvani; L. Bersaglia; E. Poluzzi; D. Motola; A. Nanetti; S. Ambretti; A. Bottoni; A. Vaccheri; N. Montanaro.
Antibiotic use in Italian hospitals 2002-2004.
2006 Silvani MC; Poluzzi E; Motola D; Strahinja P; Vargiu A; Bersaglia L; Vaccheri A; Montanaro N.
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures
2011 Lapi F.; Sessa E.; Di Bari M.; Corrao G.; Zambon A.; Scotti L.; Sturkenboom M.; Geppetti P.; Gregori D.; Carle F.; Menna A.; Vestri A.R.; Vaccheri A.; Piccinni C.; Puccini A.; Montanaro N.; Caputi A.P.; Mazzaglia G.
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures,
2011 Lapi F.; Sessa E.; Di Bari M.; Corrao G.; Zambon A.; Scotti L.; Sturkenboom M.; Geppetti .P; Gregori D.; Carle F.; Menna A.; Vestri A.R.; Vaccheri A.; Piccinni C.; Puccini A.; Montanaro N.; Arcoraci V.; Caputi A.P.; Mazzaglia G.
Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures
2013 Lapi F.; Cipriani F.; Caputi A.P.; Corrao G.; Vaccheri A.; Sturkenboom M.C.; Di Bari M.; Gregori D.; Carle F.; Staniscia T.; Vestri A.; Brandi M.; Fusco V.; Campisi G.; Mazzaglia G.
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases
2010 Poluzzi E.; Piccinni C.; Carta P.; Puccini A.; Lanzoni M.; Motola D.; Vaccheri A. ; De Ponti F.; Montanaro N.
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study
2011 Poluzzi E.; Piccinni C.; Carta P.; Puccini A.; Lanzoni M.; Motola D.; Vaccheri A.; De Ponti F.; Montanaro N.
Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions
2019 Bonaldo G.; Andriani L.A.; D'Annibali O.; Motola D.; Vaccheri A.
Changes in prevalence and pattern of drug use in a ten years period in Italy. 8th Congress of the European Association for Clinical Pharmacology and Therapeutics
2007 Silvani MC; Motola D; Poluzzi E; Strahinja P; Vargiu A; Biagi C; Vaccheri A; Montanaro N.
Comparative risk/benefit profile of biosimilar and originator erythropoiesis-stimulating agents (ESAs): data from an Italian observational study in nephrology
2018 Motola, Domenico*; Vaccheri, Alberto; Roncadori, Andrea; Donati, Monia; Bonaldo, Giulia; Covezzoli, Anna; Polidori, Piera; Bianchi, Stefano
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A 3 year survey on the use of antibacterial agents in five Italian hospitals. | Vaccheri A; Silvani MC; Bersaglia L; Motola D; Strahinja P; Vargiu A; Poluzzi E; Montanaro N. | 2008-01-01 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | - | 1.01 Articolo in rivista | - |
| A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital. | Silvani M.C.; Poluzzi E.; Motola D.; Quaranta P.; Nanetti A.; Ambretti S.; Fiacchi P.; Puggioli C....; Vaccheri A.; Montanaro N. | 2009-01-01 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Acute renal failure in patients treated with dronedarone or amiodarone: A large population-based cohort study in Italy | Conti, Valentino; Biagi, Chiara; Melis, Mauro; Fortino, Ida; Donati, Monia; Vaccheri, Alberto; Ve...negoni, Mauro; Motola, Domenico | 2015-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Aderenza al trattamento con Bifosfonati: studio di coorte retrospettivo su database amministrativi dell’Emilia Romagna | Puccini A; Piccinni C; Sacripanti C; Gadaleta A; Vaccheri A; | 2010-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage | Poluzzi E.; Strahinja P.; Vaccheri A.; Vargiu A.; Silvani M.C.; Motola D.; Marchesini G.; De Pont...i F.; Montanaro N. | 2007-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. | Poluzzi E; Strahinja P; Vargiu A; Silvani MC; Motola D; Vaccheri A; De Ponti F; Marchesini Reggia...ni G; Montanaro N. | 2006-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | - | 4.02 Riassunto (Abstract) | - |
| Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy | Poluzzi E; Strahinja P; Lanzoni M; Vargiu A; Silvani MC; Motola D; Gaddi A; Vaccheri A; Montanaro N. | 2008-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals. | Silvani MC; Bersaglia L; Poluzzi E; Motola D; Bottoni A; Strahinja P; Vargiu A; Vaccheri A; Monta...naro N. | 2007-01-01 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | - | 4.02 Riassunto (Abstract) | - |
| An update on the first decade of the European centralized procedure: how many innovative drugs? | Motola D.; De Ponti F.; Poluzzi E.; Martini N.; Rossi P.; Silvani M.C.; Vaccheri A.; Montanaro N. | 2006-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Antibacterial prescription in Italian preschool children: analysis of 7 years of data from the Emilia-Romagna region reimbursement database | D'Annibali O.; Bonaldo G.; Donati M.; Smabrekke L.; Motola D.; Vaccheri A. | 2019-01-01 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | - | 1.01 Articolo in rivista | - |
| Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital. | M. C. Silvani; L. Bersaglia; E. Poluzzi; D. Motola; A. Nanetti; S. Ambretti; A. Bottoni; A. Vacch...eri; N. Montanaro. | 2008-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | - | 4.02 Riassunto (Abstract) | - |
| Antibiotic use in Italian hospitals 2002-2004. | Silvani MC; Poluzzi E; Motola D; Strahinja P; Vargiu A; Bersaglia L; Vaccheri A; Montanaro N. | 2006-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | - | 4.02 Riassunto (Abstract) | - |
| Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures | Lapi F.; Sessa E.; Di Bari M.; Corrao G.; Zambon A.; Scotti L.; Sturkenboom M.; Geppetti P.; Greg...ori D.; Carle F.; Menna A.; Vestri A.R.; Vaccheri A.; Piccinni C.; Puccini A.; Montanaro N.; Caputi A.P.; Mazzaglia G. | 2011-01-01 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | Wiley Blackewell | 4.02 Riassunto (Abstract) | - |
| Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures, | Lapi F.; Sessa E.; Di Bari M.; Corrao G.; Zambon A.; Scotti L.; Sturkenboom M.; Geppetti .P; Greg...ori D.; Carle F.; Menna A.; Vestri A.R.; Vaccheri A.; Piccinni C.; Puccini A.; Montanaro N.; Arcoraci V.; Caputi A.P.; Mazzaglia G. | 2011-01-01 | - | Società Italiana di Farmacologia | 4.02 Riassunto (Abstract) | - |
| Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures | Lapi F.; Cipriani F.; Caputi A.P.; Corrao G.; Vaccheri A.; Sturkenboom M.C.; Di Bari M.; Gregori ...D.; Carle F.; Staniscia T.; Vestri A.; Brandi M.; Fusco V.; Campisi G.; Mazzaglia G. | 2013-01-01 | OSTEOPOROSIS INTERNATIONAL | - | 1.01 Articolo in rivista | - |
| Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases | Poluzzi E.; Piccinni C.; Carta P.; Puccini A.; Lanzoni M.; Motola D.; Vaccheri A. ; De Ponti F.; ...Montanaro N. | 2010-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | Wiley Blackewell | 4.02 Riassunto (Abstract) | - |
| Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study | Poluzzi E.; Piccinni C.; Carta P.; Puccini A.; Lanzoni M.; Motola D.; Vaccheri A.; De Ponti F.; M...ontanaro N. | 2011-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions | Bonaldo G.; Andriani L.A.; D'Annibali O.; Motola D.; Vaccheri A. | 2019-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | - | 1.01 Articolo in rivista | - |
| Changes in prevalence and pattern of drug use in a ten years period in Italy. 8th Congress of the European Association for Clinical Pharmacology and Therapeutics | Silvani MC; Motola D; Poluzzi E; Strahinja P; Vargiu A; Biagi C; Vaccheri A; Montanaro N. | 2007-01-01 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Comparative risk/benefit profile of biosimilar and originator erythropoiesis-stimulating agents (ESAs): data from an Italian observational study in nephrology | Motola, Domenico*; Vaccheri, Alberto; Roncadori, Andrea; Donati, Monia; Bonaldo, Giulia; Covezzol...i, Anna; Polidori, Piera; Bianchi, Stefano | 2018-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |